CompletedNot Applicable

A Patient-Centered Intervention to Improve Opioid Safety

United States286 participantsStarted 2016-03-23

Plain-language summary

This is a randomized controlled trial of a multifaceted intervention designed to improve the safety of opioid prescribing. The specific aims of this study are to: (a) evaluate whether a multifaceted intervention (Improving the Safety of Opioid Prescribing; ISOP) enhances opioid safety, (b) assess whether participation in ISOP impacts the clinician-patient relationship, and (c) explore to what extent ISOP is associated with changes in pain and pain-related function.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Enrollment in primary care at the VA Portland Health Care System * Receiving long-term opioid therapy (for at least 3 months) for chronic pain unrelated to a life-limiting disease * Able to read and write in English Exclusion Criteria: * Age younger than 18 years old * On opioid therapy for palliative or end-of-life care * Current enrollment in an opioid substitution program * Lack of access to a telephone

What they're measuring

Current Opioid Misuse Measure (COMM)

Timeframe: Data collected at baseline, 6 months, and 12 months.

Urine Drug Test

Timeframe: Data collected at baseline, 6 months, and 12 months

Trial details

NCT IDNCT02791399

SponsorVA Office of Research and Development

Sponsor typeFED

Study typeINTERVENTIONAL

Primary completion2019-10-15

Results submitted2021-04-26

View on ClinicalTrials.gov More Opioid Safety trials